CliffBio
small molecule

MONOKET

ISOSORBIDE MONONITRATE

Loss of exclusivity—loss of exclusivity
CompanyOMNIVIUM PHARMACEUTICALS LLC

Drug detail

Brand nameMONOKET
Active ingredientISOSORBIDE MONONITRATE
Strength10MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJune 1993
Marketing statusRX

More from OMNIVIUM PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.